These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Systemic Bacillus Calmette-Guerin sepsis manifesting as autoimmunity, 17 months after an intravesical BCG-therapy]. Goulabchand R; Dufour S; Murez T; Broner J; Rivière S; Guilpain P; Le Quellec A Med Mal Infect; 2017 Dec; 47(8):558-561. PubMed ID: 28943176 [No Abstract] [Full Text] [Related]
29. A case of granulomatous hepatitis after intravesical bacillus Calmette-Guerin administration. Graziano DA; Jacobs D; Lozano RG; Buck RL J Urol; 1991 Oct; 146(4):1118-9. PubMed ID: 1895437 [TBL] [Abstract][Full Text] [Related]
30. Immunotherapy with bacille Calmette-Guérin in patients with superficial transitional cell carcinoma of the bladder associated with bilharziasis. Wishahi MM; Ismail IM; el-Sherbini M Br J Urol; 1994 Jun; 73(6):649-54. PubMed ID: 8032832 [TBL] [Abstract][Full Text] [Related]
31. Left Anterior Descending Coronary Artery and Multiple Peripheral Mycotic Aneurysms Due to Mycobacterium Bovis Following Intravesical Bacillus Calmette-Guerin Therapy: A Case Report. Duvnjak P; Laguna M J Radiol Case Rep; 2016 Aug; 10(8):12-27. PubMed ID: 27761190 [TBL] [Abstract][Full Text] [Related]
32. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma. Proctor DD; Chopra S; Rubenstein SC; Jokela JA; Uhl L Am J Gastroenterol; 1993 Jul; 88(7):1112-5. PubMed ID: 8317415 [TBL] [Abstract][Full Text] [Related]
36. Histopathology of Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Immunotherapy for Urothelial Carcinoma. Larsen BT; Smith ML; Grys TE; Vikram HR; Colby TV Int J Surg Pathol; 2015 May; 23(3):189-95. PubMed ID: 25614462 [TBL] [Abstract][Full Text] [Related]
37. Use of maintenance intravesical bacillus Calmette-Guérin (BCG), with or without intradermal BCG, in patients with recurrent superficial bladder cancer. Long-term follow-up of a randomized phase 2 study. Witjes JA; Fransen MP; van der Meijden AP; Doesburg WH; Debruyne FM Urol Int; 1993; 51(2):67-72. PubMed ID: 8351757 [TBL] [Abstract][Full Text] [Related]
38. Systemic hypersensitivity reaction to intravesical BCG. Lyons D; Miller I; Jeffers A Scott Med J; 1994 Apr; 39(2):49-50. PubMed ID: 8720760 [TBL] [Abstract][Full Text] [Related]
39. Mycobacterium bovis vertebral osteomyelitis and psoas abscess after intravesical BCG therapy for bladder carcinoma. Katz DS; Wogalter H; D'Esposito RF; Cunha BA Urology; 1992 Jul; 40(1):63-6. PubMed ID: 1621315 [TBL] [Abstract][Full Text] [Related]
40. Mycobacterium bovis infection of an implantable defibrillator following intravesical therapy with bacille Calmette-Guérin. Stone DR; Estes NA; Klempner MS Clin Infect Dis; 1993 Jun; 16(6):825-6. PubMed ID: 8329515 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]